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Studies suggest that GAD1 gene was a functional candi-
date susceptibility gene for cerebral palsy (CP). In order 
to investigate the contribution of GAD1 gene to the etiology 
of CP in Chinese infants, we carried out a case-control 
association study between GAD1 gene and CP. In this 
study, 374 health controls and 392 infants with CP were 
recruited. Genomic DNA was extracted from venous blood 
and all three single nucleotide polymorphisms in GAD1 
(rs3791874, rs3791862 and rs16858977) were genotyped by 
Sequenom’s MassARRAY system. There were no significant 
differences in allele or genotype frequencies between CP or 
mixed CP patients and controls at any of the three genetic 
polymorphisms. Through haplotype analysis we found that 
haplotype GG (rs3791862, rs16858977) frequency demon-
strated significantly statistical difference between mixed CP 
patients and controls (p= 0.0371). Our positive findings of 
haplotype GG suggested that variation of GAD1 gene was 
an important risk factor for mixed CP.
Keywords: glutamate decarboxylase 1; single nucleotide 
polymorphism; haplotype; mixed CP.
Introduction. Cerebral palsy (CP), which usually 
occurs in the developing fetal and infant, is de-
fined as a non-progressive but not unchanging 
disorder of posture or movement resulting from 
an abnormality of the brain [1, 2]. The major 
clinical manifestations include spastic diplegia, 
mental retardation, hyperreflexia, clumsiness, uns-
table gait and drooling. Different individuals have 
some phenotypic variability, but spastic diplegia, 
and mental retardation are three constant traits 
presented in all affected individuals [3]. According to 
the overall clinical picture, CP can be classified into 
such subgroups as dyskinetic, ataxic, spastic and mi-
xed CP [4, 5]. Approximately 2–3/1000 live births 
present with CP, which makes it one of the most 
common physical disability of childhood [6]. Although 
the aetiology of CP has been attributed to a variety 
of factors, the detailed mechanisms underlying most 
cases remain elusive. Asphyxia, neuronal disorders, 
infections in utero, amnionitis, maternal autoimmune 
disease, metabolic disease, vascular lesions, as well as 
coagulation disorders all have been considered as risk 
factors for CP [7].  It is unknown that how the fetus 
responds in the presence of these risk factors and how 
the genetic makeup influence the fetus response on 
the condition that some genotypes create suscep-
tibility to cerebral damage. To date, a lot of case-
control studies have been carried out to investigate 
the association between genetic polymorphisms and 
CP. These studies have explored many genes, such as 
interleukin-6 (IL-6), apolipoprotein E (APOE), and 
cytokine, but the association between GAD1 and CP 
has not been investigated [8–10].
GAD1, 46kb in length, with 17 exons, located in 
2q31, codes for the 67 kDa isoform (GAD67) of 
L-glutamate decarboxylase. GAD67 is one of the two 
major isoforms of GAD, an enzyme that converts 
glutamate to GABA. The other isoform, GAD65, 
is encoded by the gene GAD2. GAD67 exists as 
both homo- and heterodimers in both soluble and 
membrane-bound forms, primarily within the cell 
soma but also to a limited degree in terminals [4, 
11]. A great many of evidences indicated that GAD1 
played more and more important role in  nerve 
system disease such as  autism and schizophrenia. 
Many studies on the association between GAD1 
and nerve system diseases have been conducted 
and their results proved that the abruption of GAD1 
gene was an important risk factor to the happening 
of schizophrenia, autism and child bipolar I disorder 
[11–14]. There was also a study which demonstrated 
that GAD1 was associated with cortical gray matter 
volume loss in schizophrenia [15]. In addition, the 
linkage between GAD1 and cerebral palsy has been 
explored and the linkage region has been mapped 
to chromosome 2q24–25. A missense mutation 
in GAD67 was detected, which was segregated 
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with CP in affected individuals [4, 16]. However, 
whether the association between GAD1 and cerebral 
palsy in population exists has not been known yet. 
In order to investigate the association, we enrolled 
374 health controls and 392 infants with CP. The 
association analysis showed that no significant 
differences existed in allele or genotype frequencies 
between CP and controls. However, gene GAD1 
with GG haplotype would more possibly increase 
the incidence of mixed CP.  
Materials and methods. Subjects. The study pop-
ulation was comprised of 392 CP patients (118 girls 
30.1 %, 274 boys 69.9 %, mean age ± s.d.: 18.25 ± 
± 14.64 months) chosen from center for CP rehabil-
itation in the Third Affiliated Hospital of Zhengzhou 
University, Zhengzhou Children’s Hospital and the 
First Affiliated Hospital of the Henan Traditional 
Chinese Medical College from 1 May 2008 to 31 
Oct 2009. Among the 392 cases, 159 cases suffered 
from spastic quadriplegia cerebral palsy and 93 cases 
suffered from mixed cerebral palsy. The 374 healthy 
controls included in the study were selected from 
the Child Healthcare Department at the same hos-
pital during the same period and were matched for 
age, sex and ethnicity (154 girls 41.18 %, 220 boys 
58.82 %, mean age ± s.d.: 18.40 ± 19.55 months). 
All subjects including CP patients and healthy con-
trols belonged to Chinese Han population and writ-
ten informed consent was asked from each subject. 
Symptoms of CP patients were assessed by a child 
neurologist with clinical examination or with medi-
cal records. This study was approved by the ethics 
committee of Zhengzhou University in accordance 
with the Helsinki declaration.   
SNP selection. In this study, the SNP was se-
lected according to the criterion of heterozygos-
ity more than 15 % and minor allele frequencies 
(MAF) more than 5 %. A total of three SNPs were 
selected. Rs3791874 in intron 2 was selected be-
cause it was close to missense mutation (G36C) 
[4]. We consulted the HapMap database (re-
lease#2, population: Han Chinese in Beijing) and 
selected tagging SNP rs3791862 in intron 3. In the 
middle part of gene GAD1 rs16858977 (intron 7) 
was selected since it could represent the largest 
block according to LD heat plot and CHB phased 
haplotypes in HapMap database.   
Genotyping. Genomic DNA was extracted from 
venous blood using AxyPrep Blood Genomic DNA 
Miniprep Kit (Axygen Biosciences, Union city, CA, 
USA) and following the recommended procedure. 
SNP genotyping was performed using Sequenom’s 
MassARRAY system (San Diego, California, USA) 
according to the manufacturers’ specifications. Re-
sults were analyzed with Typer4.0 software (Seque-
nom). Those whose genotype results were analyzed 
were blind to the clinical data.
Statistical analysis. We conducted Hardy–Wein-
berg equilibrium tests with Hardy–Weinberg test 
3.0.xls, allele and genotype frequency,  linkage dis-
equilibrium and haplotype analysis with the SHE-
SIS software. The haplotype blocks were defined 
as Dƍ ˚0.8. Linkage disequilibrium was measured 
using standardized Dƍ and r2, and the discrepancies 
in allele and genotype frequencies on single locus be-
tween patients and controls were compared using a 
Fisherƍs exact test strategy. The numbers of observa-
tions for each haplotype were compared using Ȥ2 tests 
Table 1. Allele and genotype frequencies of SNPs in GAD1
Group Allele frequency P Genotype  frequency P H-W
rs3791874
CP
MCP
Control
rs3791862
CP
MCP
Control
rs16858977
CP
MCP
Control
G
425 (0.5491) 
28 (0.5385) 
404 (0.5504) 
G
559 (0.7222) 
39 (0.7800) 
527 (0.7199) 
C 
237 (0.3329) 
13 (0.2708) 
225 (0.3348) 
T 
349 (0.4509)
26 (0.4615)
330 (0.4496)
T
215 (0.2778)
11 (0.2200)
205 (0.2801)
G
475 (0.6671)
35 (0.7292)
447 (0.6652)
0.9591
0.6495
0.9216
0.3582
0.9385
0.3626
G/G
112 (0.2894) 
7 (0.2593)
106 (0.2888)
G/G
196 (0.5065)
14 (0.5600)
192 (0.5246)
C/C
37 (0.1093)
1 (0.0417)
30 (0.0893)
T/T
74 (0.1912) 
6 (0.2222)
69 (0.1880)
T/T
24 (0.0620)
0 (0.0000)
31 (0.0847)
G/G
156 (0.4382)
12 (0.5000)
141 (0.4196)
G/T
201(0.5194)
14 (0.5185)
192 (0.5232)
G/T
167 (0.4315)
11 (0.4400)
143 (0.3907)
C/G
163 (0.4579)
11 (0.4583)
165 (0.4911)
0.9922
0.8903
0.3319 
0.3139
0.6301
0.6129
0.3363
0.8420
0.2743
0.1375
0.1580
0.5520
0.5597
0.0030
0.0604
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between cerebral group and control group or between 
mixed cerebral palsy (MCP) sub-group and control. 
Correction of permutation test was applied to haplo-
type analysis. All reported P-values were two-tailed 
and statistical significance was set at P < 0.05.
Results. In this association study using 392 CP 
patients and 374 healthy controls, we tested three 
SNPs in GAD1 gene. The genotypic distribution 
of the three SNPs was in Hardy–Weinberg equi-
librium in both the patient group (except rs16858977 
in MCP group) and the control group. Allele 
frequencies and genotypic distribution analysis of 
individual SNPs are shown in Table 1. For the 
totality of the subjects, there were no significant 
differences of allele or genotype frequencies 
between CP patients and controls at any of the 
three genetic polymorphisms. The similar results 
were observed between MCP and controls.
We investigated LD for all possible two-way 
comparisons among the three selected SNPs 
in GAD1. Analysis of Dƍ revealed strong linkage 
disequilibrium (Dƍ > 0.8) between rs3791874 and 
Table 2. The linkage disequilibrium among the SNPs
Index Case MCP
Dƍ/r2
rs3791874
rs3791862
rs16858977
rs3791874
0.443
0.000
rs3791862
0.968
0.207
rs16858977
0.147
0.988
rs3791874
0.444
0.008
rs3791862
0.979
0.196
rs16858977
0.140
0.976
Table 3. Estimated GAD1 haplotype frequencies 
Haplotype
Frequency
P-value OR (95 % CI)
CP Controls
rs3791874, rs3791862
G G
T G
T T
415.99(0.5445)
134.01(0.1754)
210.02(0.2749)
395.01(0.5471)
125.99(0.1745)
198.98(0.2756)
0.9617
0.9470
0.9975
0.9950(0.8107, 1.2212)
1.0091(0.7720, 1.3191)
0.9996(0.7959, 1.2555)
rs3791862, rs16858977
G C 
G G  
T G  
235.03(0.3329)
262.00(0.3711)
208.98(0.2960)
219.98(0.3323)
243.02(0.3671)
198.00(0.2991)
0.9990
0.8940
0.8872
1.0001(0.7985, 1.2526)
1.0151(0.8148, 1.2646)
0.9833(0.7798, 1.2401)
Table 4. Estimated GAD1 haplotype frequencies 
Haplotype
Frequency
P-value OR (95 % CI)
MCP Controls
rs3791874, rs3791862
G G
T G
T T
28.00 (0.5600) 
11.00 (0.2200) 
11.00 (0.2200) 
395.01 (0.5471)
125.99 (0.1745)
198.98(0.2756)
0.8756
0.4211
0.3866
1.0472 (0.5879, 1.8654)
1.3297 (0.6628, 2.6675)
0.7384 (0.3708, 1.4704)
rs3791862, rs16858977
G C 
G G  
T G  
12.00(0.2609) 
24.00(0.5217) 
10.00(0.2174) 
219.98(0.3323)
243.02(0.3671)
198.00(0.2991)
0.3149
0.0371
0.2371
0.7075(0.3592, 1.3933)
1.8765(1.0301, 3.4184)
0.6496(0.3161, 1.3346)
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rs3791862 or between rs3791862 and rs16858977. 
However, no linkage disequilibrium was observed 
between rs3791874 and rs16858977 (Table 2). Then 
we analyzed haplotype frequency in which rare 
haplotypes with a frequency less than 0.03 were 
dropped. In total, four individual haplotypes were 
observed and three showed a frequency greater 
than 3 %, among which no haplotype distribution 
produced positive results (Table 3) in CP group. 
In the exploratory analysis, where the sample was 
sub-grouped according to the clinical symptoms, 
significant evidence of preferential sharing of the 
haplotype GG in MCP subgroup (p = 0.0371) was 
compared with control group (Table 4). 
Discussion. Cerebral palsy comprises a group of 
permanent and non-progressive disorders of movement 
and posture caused by a central nervous lesion, damage 
or dysfunction originating early in life [17]. Although 
the  aetiology of CP has been attributed to a variety of 
factors, the specific mechanism underlying most cases 
remains unknown. The efforts to reduce the incidence 
of perinatal brain injury in term infants have failed 
despite the improvement in obstetric and neonatal 
care [18, 19]. The genetic factors affecting CP have 
attracted more attention from researchers in recent 
years [20–22]. Many candidate genes have been found 
and identified as risk factors for CP. These candidate 
genes were categorized as cytokine, thrombophilic, 
apolipoprotein E and a group related to cardiovascular 
disease or functions of immune system. But the 
association study on candidate gene such as GAD1 
related to nervous system development hasnƍt been 
reported yet.
In the present study of Chinese infants, there 
were no significant differences of allele or genotype 
frequencies between CP patients and controls at any 
of the three GAD1 gene polymorphisms. The results 
may be owing to these three SNPs are all located in 
intron and they are not functional variants of GAD1. 
Then we performed the haplotype analysis. The 
haplotype (rs3791874 and rs3791862) did not show 
any significant difference between CP group and 
controls probably because the range from rs3791874 
to rs3791862 did not cover any natural variant or 
contain any functional region according to UniProt 
database. Thus we speculated that the haplotype 
(rs3791874 and rs3791862) probably did not alter 
the protein product of the gene and its catalytic 
activity. Similarly, the haplotype (rs3791862 and 
rs16858977) did not show any significant difference 
between CP group and controls probably due to the 
occurrence of cerebral palsy attributed to a variety 
of risk factors. However, further analysis showed 
that the haplotype GG (rs3791862, rs16858977) 
distribution revealed a significant difference bet-
ween mixed CP patients and controls. Linkage 
disequilibrium tests demonstrated a strong linkage 
disequilibrium (Dƍ > 0.8) between rs3791874 and 
 rs3791862 or between rs3791862 and rs16858977. 
However, no marked linkage disequilibrium was 
found between rs3791874 and rs16858977. Given this, 
we supposed that rs3791862 was a newly formed SNP 
and might evolve because of gene-tic drift or positive 
Darwinian selection [23, 24]. According to this theory, 
the individuals with heterozygous status at rs3791862 
should present a prominent linkage disequilibrium 
between rs3791874 and rs16858977 and our results 
verified the hypothesis (Dƍ = 0.95). Based on this, 
the haplotype (rs3791874, rs3791862 and rs16858977) 
were analyzed and results showed that the hap-
lotype TGG distribution revealed a significant dif-
ference between CP group and controls (p = 
= 0.028) or between spastic quadriplegia CP group 
and controls (p = 0.0358) or between mixed CP 
group and controls (p = 0.0052) (data not shown). 
These results provided a positive support for the 
haplotype GG as a risk factor for the occurrence of 
mixed CP. The significant difference of haplotype 
GG between mixed CP patients and controls was 
further supported by the genotype distribution in 
mixed CP group which displayed a prominent 
Hardy–Weinberg disequilibrium. In addition, the 
coverage area of selected SNPs added up to 64.23 % 
in the whole GAD1 gene according to LD plot of 
CHB population in HapMap database. Based on 
these data, we speculated that  gene GAD1 with 
haplotype GG should more possibly contribute to the 
occurrence of mixed CP. 
There was a study documenting that 24 % of 
term infants with CP had evidence of encepha-
lopathy in the newborn period. Neonates with 
encephalopathy had significant deficits, memory 
impairment, visual  dysfunction and increased hy-
peractivity. MCP is usually the spastic CP and 
the athetoid CP which combine to cause many 
disabilities in a child. Generally mixed CP was 
more severely affected and more often had dys-
gnosia, cerebral visual impairment and dyskinesia 
[17, 25, 26]. In our study, the majority of patient 
samplesˈespecially MCP, have one or more of 
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the following features: dysnoesia, dysarthria, vi-
sual perceptive dysfunction and hearing impair-
ment. Spastic quadriplegia was often associated 
with cortical and subcortical white matter damage 
or extensive necrosis in the brain [27]. Based on 
these facts, we could see that CP, especially mixed 
CP, was more often caused by the cerebral injury. 
The Ȗ-aminobutyric acid (GABA) was synthesized 
by GAD67 in neurons and served as neurotrans-
mitters/neuromodulators in the regulation of the 
circulation and permeability of the intrinsic mi-
crovessels within the central nervous system (CNS) 
[28, 29]. Baclofen, as a GABA  agonist, was used 
to reduce muscle tone in CP children and to de-
crease spasticity and furthermore, improvement in 
comfort and function were both observed. All these 
studies implied that GAD1 was involved in occur-
rence of CP. These facts were consistent with our 
findings that gene GAD1 was associated with  the 
occurrence of CP, especially mixed CP.    
Gender related pathophysiological features are 
thought to be related to CP [30]. Therefore, we 
checked the gender differences in genetic suscepti-
bility to CP, but found no association between the 
three GAD1 gene polymorphisms and CP. Prema-
turity is another important contributor to CP [31]. 
Gestation age differences with genetic susceptibil-
ity to CP were also compared in our study, but no 
difference was observed with respect to the GAD1 
gene polymorphisms.
In conclusion, our results showed that none of 
the three SNPs in GAD1 contribute to the occur-
rence of CP in Chinese infants. However, gene 
GAD1 with GG haplotype is preferentially a risk 
factor for the occurrence of mixed CP. To our 
knowledge, this is the first report to demonstrate 
that GAD1 is associated with occurrence of mixed 
CP. Nonetheless, it should be stated that our find-
ings are still preliminary and have many limitations 
such as fewer SNPs, small sample size of mixed CP 
and limited coverage field in the gene. Therefore, 
the further study is warranted. 
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ÑÂßÇÜ ÌÅÆÄÓ ÏÎËÈÌÎÐÔÈÇÌÀÌÈ ÃÅÍÀ 
GAD1 È ÖÅÐÅÁÐÀËÜÍÛÌ ÏÀÐÀËÈ×ÎÌ Ó 
ÊÈÒÀÉÑÊÈÕ ÄÅÒÅÉ
Ïðåäïîëàãàåòñÿ, ÷òî ãåí GAD1 ÿâëÿåòñÿ ôóíêöèî-
íàëüíûì êàíäèäàòîì íà ðîëü ãåíà ïîäâåðæåííîñòè 
öåðåáðàëüíîìó ïàðàëè÷ó (ÖÏ). Äëÿ èññëåäîâàíèÿ 
âêëàäà ãåíà GAD1 â ýòèîëîãèþ ÖÏ ó êèòàéñêèõ äåòåé 
ìåòîäîì ñëó÷àé – êîíòðîëü ïðîâåäåíî èññëåäî-
âàíèå àññîöèàöèè ìåæäó íàëè÷èåì ãåíà GAD1 è 
ÖÏ. Â èññëåäîâàíèè áûëè çàäåéñòâîâàíû 374 çäî-
ðîâûõ ðåáåíêà (êîíòðîëü) è 392 ðåáåíêà ñ ÖÏ. 
Ãåíîìíóþ ÄÍÊ âûäåëÿëè èç âåíîçíîé êðîâè, è 
âñå òðè åäèíè÷íûõ íóêëåîòèäíûõ ïîëèìîðôèçìà 
ãåíà GAD1 (rs3791874, rs3791862 è rs16858977) áûëè 
ãåíîòèïèðîâàíû â ñèñòåìå Sequenom MassARRAY. 
Íè äëÿ îäíîãî èç òðåõ ãåíåòè÷åñêèõ ïîëèìîðôèç-
ìîâ íå îáíàðóæåíî ñóùåñòâåííûõ ðàçëè÷èé â ÷àñ-
òîòàõ àëëåëåé èëè ãåíîòèïîâ ìåæäó áîëüíûìè ÖÏ 
èëè ñìåøàííûìè áîëüíûìè ÖÏ è êîíòðîëåì. Àíà-
ëèç ãàïëîòèïîâ ïîêàçàë ñóùåñòâåííûå ñòàòèñòè-
÷åñêèå ðàçëè÷èÿ â ÷àñòîòå ãàïëîòèïà GG (rs3791862, 
rs16858977) ó ñìåøàííûõ áîëüíûõ ÖÏ è êîíòðîëü-
íîé ãðóïïû (p = 0.0371). Ïîçèòèâíûé ðåçóëüòàò ïî 
ãàïëîòèïó GG ñâèäåòåëüñòâóåò î òîì, ÷òî âàðèàöèÿ 
ãåíà GAD1 ÿâëÿåòñÿ âàæíûì ôàêòîðîì ðèñêà äëÿ 
ñìåøàííîãî ÖÏ. 
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